NPI 1285909234: Open Payments
NPI 1285909234. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 14 payments from 8 companies in 2025. Trend: 2023 $1,402 · 2024 $846 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $60 |
| Novo Nordisk Inc | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $27 |
| Dexcom, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| SANOFI PASTEUR INC. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Ozempic, NURTEC ODT, TRELEGY ELLIPTA, Dexcom G6 Transmitter, INSPIRE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Kerendia, GARDASIL 9.
